Principal Investigators: Frederick Naftolin, PhD
e-Bio is a clinical-stage medical device company developing an innovative solution to stop preterm labor. After years of animal studies, e-Bio was granted authorization from the FDA for studies in humans, which they are currently conducting. e-Bio’s proprietary technology is based on the concept of electric inhibition, meaning that by using an electric signal they are able to affect uterine contractions. By applying this stimulation towards the women’s uterus, they can diminish or stop contractions on preterm pregnancies.